Adaptive Biotechnologies Corp.
(NASDAQ : ADPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
FLTFleetCor Technologies, Inc.
-2.43%293.143.4%$154.56m
ETSYEtsy, Inc.
-2.33%54.097.9%$149.77m
EFXEquifax Inc.
-1.42%141.872.0%$134.16m
CTASCintas Corporation
-3.21%256.044.6%$128.48m
ZZillow Group, Inc. Class C
-2.57%34.5110.2%$103.52m
CPRTCopart, Inc.
-3.36%73.684.5%$89.38m
ITGartner, Inc.
-2.35%129.462.4%$86.40m
TRUTransUnion
-2.06%82.190.9%$81.15m
BAHBooz Allen Hamilton Holding Corporation Class A
-2.00%73.472.0%$76.56m
XRXXerox Corporation
-2.87%27.796.1%$74.66m
BZUNBaozun Inc Sponsored ADR Class A
-4.40%40.401.7%$74.31m
MDSOMedidata Solutions, Inc.
-0.12%91.507.3%$71.58m
KARKAR Auction Services, Inc.
-3.38%24.611.4%$67.84m
GGenpact Limited
-2.19%39.686.9%$66.93m
PRAHPRA Health Sciences, Inc.
-2.41%95.372.4%$61.18m

Company Profile

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.